CD19 and graft versus host disease: In comparison with HLA-identical sibling and 10/10 allelic-matched unrelated donor transplants, αβ/CD19+ haplo HSCT had a lower incidence of grade 3-4 acute GvHD, of visceral GvHD, and of chronic GvHD.